The organomercurial 4-aminophenylmercuric acetate, independent of matrix metalloproteinases, induces dose-dependent activation/inhibition of platelets aggregation

Thrombosis and Haemostasis

Volumn 93, Issue 2, 2005, Pages 326-330

  Rosenfeldt, Mathias T ^a,c   Valentino, Michael ^a   Labruzzo, Salvatore ^a   Scudder, Lesley ^b   Pavlaki, Maria ^b   Cao, Jian ^b   Vacirca, Jeffrey ^a,b   Bahou, Wadie F ^b   Zucker, Stanley ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

4 aminophenylmercuric acetate (APMA); Matrix metalloproteinases (MMP); Platelet aggregation

Indexed keywords

1,10 PHENANTHROLINE; 4 AMINOPHENYLMERCURIC ACETATE; ACETYLSALICYLIC ACID; CALCIUM; COMPLEMENTARY DNA; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; THROMBOXANE; ZINC;

ARTICLE; BLOOD SAMPLING; CALCIUM SIGNALING; CELL ISOLATION; CHELATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ISOLATION; ENZYME PURIFICATION; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; ULTRAFILTRATION;

CALCIUM SIGNALING; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; METALLOPROTEASES; PHENYLMERCURIC ACETATE; PLATELET AGGREGATION; THROMBOXANES; ZINC;

EID: 13844266456     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-08-0541     Document Type: Article

References (31)

1. Somerville RPT, et al. Matrix metalloproteinases: old dogs with new tricks. Genome Biol 2003; 4: 216.
2. Sawicki G, et al. Release of gelatinase A during platelet activation mediates aggregation. Nature 1997; 386: 616-9.
3. Fernandez-Patron C, et al. Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2. Thromb Haemost 1999; 82: 1730-5.
4. Galt SW, et al. Outside-in signals delivered by matrix metalloproteinase-1 regulate platelet function. Circ Res 2002; 90: 1093-9.
5. Radomski A, et al. Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human platelets. Br J Pharmacol 2002; 137: 1330-8.
6. Kazes I, Elalamy I, Sraer JD, et al. Platelet release of trimolecular complex components MT1-MMP/TIMP2/MMP2: involvement in MMP2 activation and platelet aggregation. Blood 2000; 96: 3064-9.
7. Sawicki G, Sanders EJ, Salas E, et al. Localization and translocation of MMP-2 during aggregation of human platelets. Thromb Haemost 1998; 80: 836-9.
8. Jurasz P, et al. Matrix metalloproteinase-2 contributes to increased platelet reactivity in patients with metastatic prostate cancer: a preliminary study. Thromb Res 2003; 112: 59-64.
9. Cheung PY, et al. Inhaled nitric oxide inhibits the release of matrix metalloproteinase-2, but not platelet activation, during extracorporeal membrane oxygenation in adult rabbits. J Pediatr Surg 2003; 38: 534-8.
10. Jurasz P, Chung AW, Radomski A, et al. Nonremodeling properties of matrix metalloproteinases: the platelet connection. Circ Res 2002; 90: 1041-3.
11. Radomski A, et al. Pharmacological characteristics of solid-phase von Willebrand factor in human platelets. Br J Pharmacol 2001; 134: 1013-20.
12. Martinez A, et al. Matrix metalloproteinase-2 in platelet adhesion to fibrinogen: interactions with nitric oxide. Med Sci Monit 2001; 7: 646-51.
13. Jurasz P, et al. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide. Cancer Res 2001; 61: 376-82.
14. Alonso-Escolano D, et al. Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins. Br J Pharmacol 2004; 141: 241-52.
15. Springman EB, et al. Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc Natl Acad Sci 1990; 87: 364-8.
16. Cao J, et al. The propeptide domain of membrane type 1 matrix metalloproteinase is required for binding of tissue inhibitor of metalloproteinases and for activation of pro-gelatinase A. J Biol Chem 1998; 273: 34745-52.
17. Toth M, et al. Phorbol ester-induced cell surface association of matrix metalloproteinase-9 in human MCF10A breast cancer cells. Cancer Res 1997; 57: 3159-67.
18. Cao J, et al. Membrane type matrix metalloproteinase 1 activates pro-gelatinase A without furin cleavage of the N-terminal domain. J Biol Chem 1996; 271: 30174-80.
19. Knight CG, et al. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett 1992; 296: 263-6.
20. Taylor ML, et al. The effects of varying doses of ASA on human platelet activation induced by PAF, collagen and arachidonic acid. Br J Clin Pharmacol 1992; 33: 25-31.
21. 3 independently of other receptors. Blood 2004; 103: 3403-11.
22. Sun, Y, et al. Activation of p53 transcriptional activity by 1, 10-phenanthroline, a metal chelator and redox sensitive compound. Oncogene 1997; 14: 385-93.
23. Van Gorp RMA, et al. Effect of membrane-permeable sulfhydryl reagents and depletion of glutathione on calcium mobilization in human platelets. Biochem Pharmacol 1997; 53: 1533-42.
24. Ball G, et al. Effect of some inhibitors of platelet aggregation on platelet nucleotides. Biochem J 1969; 114: 669-71.
25. Elferink JGR. Thimerosal: a versatile sulfhydryl reagent, calcium mobilizer, and cell function-modulating agent. Gen Pharmacol 1999; 33: 1-6.
26. Kostka B, Wachowiz B. Effect of mercurial compounds on adenine nucleotides of washed pig platelets. Environmental Res 1983; 30: 420-6.
27. Goodwin CA, et al. Increased expression of procoagulant activity on the surface of human platelets exposed to heavy-metal compounds. Biochem J 1995; 308: 15-21.
28. Yan B, Smith JW. Mechanism of integrin activation by disulfide bond reduction. Biochemistry 2001; 40: 8861-7.
29. Essex DW, Li M. Redox control of platelet aggregation. Biochemistry 2003; 42: 129-36.
30. Bergmeier W, et al. Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro-aged or -injured mouse platelets. Blood 2003; 102: 4229-35.
31. Merlos-Suárez A, et al. Metalloprotease-dependent protransforming growth factor-alpha ectodomain shedding in the absence of tumor necrosis factor-alpha-converting enzyme. J Biol Chem 2001; 276: 48510-7.